Source: PR NEWSWIRE

Press Release: Avid Radiopharmaceuticals : Lilly Joins the Imaging Dementia - Evidence for Amyloid Scanning (IDEAS) Study

INDIANAPOLIS, Oct. 7, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, today announced financial commitment and continued scientific partnership to support the recently established Imaging Dementia -...

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
100-250
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100



Avid Radiopharmaceuticals, Inc., is a Private company. Avid Radiopharmaceuticals, Inc.,'s parent company has been Lilly Eli & Co since Dec 2011.